Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review

Tiffany L. Sarrafian, Sue C. Bodine, Brian G Murphy, J. Kevin Grayson, Susan M Stover

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Objective: Large muscular or musculotendinous defects present a dilemma because of the inadequacies of current treatment strategies. Extracellular matrices (ECM) are potential clinically applicable regenerative biomaterials. This review summarizes information from the preclinical literature evaluating the use of ECM for muscle regeneration in animal models of volumetric muscle loss (VML). Study Design: Literature review. Sample population: Animal models of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Methods: PubMed, Google Scholar, CAB abstracts, and Scopus were searched for preclinical studies using ECM in animal models of VML. The search terms “extracellular matrix,” “VML,” “muscle regeneration,” “cell seeded,” and “scaffold” identified 40 articles that met inclusion criteria of an animal model of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Key skeletal muscle repair mechanisms and experimental findings on scaffold type, VML location, and experimental animal species were summarized. Conclusions: Satellite cells and basal lamina are key endogenous contributors to skeletal muscle regeneration. ECM as a dynamic tissue component may provide structural integrity, signaling molecules, and a 3-dimensional topography conducive to muscle regeneration. Preclinical models of muscle repair most commonly used mice and rats (88%). Most experimental lesions were created in abdominal wall (33%), anterior tibialis (33%), latissimus dorsi (10%), or quadriceps (10%) muscles. Matrices varied markedly in source and preparation. Experimental outcomes of ECM and cell-seeded ECM implantation for muscle regeneration in VML were highly variable and dependent on matrix tissue source, preparation method, and anatomic site of injury. Scar tissue formation likely contributes to load transfer. Nonappendicular lesions had better regenerative results compared with appendicular VML. Clinical significance: The preponderance of current evidence supports the use of ECM for muscle defect repair only in specific instances, such as nonappendicular and/or partial-thickness defects. Consequently, clinical use of ECM in veterinary patients requires careful consideration of the specific ECM product, lesion size and location, and loading circumstances.

Original languageEnglish (US)
Pages (from-to)524-535
Number of pages12
JournalVeterinary Surgery
Volume47
Issue number4
DOIs
StatePublished - May 1 2018

Fingerprint

extracellular matrix
Extracellular Matrix
Muscles
muscles
Wounds and Injuries
muscle development
Regeneration
animal models
Animal Models
lesions (animal)
cells
skeletal muscle
Skeletal Muscle
Population
biocompatible materials
laminae (animals)
Superficial Back Muscles
Quadriceps Muscle
Biocompatible Materials
Abdominal Wall

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Extracellular matrix scaffolds for treatment of large volume muscle injuries : A review. / Sarrafian, Tiffany L.; Bodine, Sue C.; Murphy, Brian G; Grayson, J. Kevin; Stover, Susan M.

In: Veterinary Surgery, Vol. 47, No. 4, 01.05.2018, p. 524-535.

Research output: Contribution to journalReview article

Sarrafian, Tiffany L. ; Bodine, Sue C. ; Murphy, Brian G ; Grayson, J. Kevin ; Stover, Susan M. / Extracellular matrix scaffolds for treatment of large volume muscle injuries : A review. In: Veterinary Surgery. 2018 ; Vol. 47, No. 4. pp. 524-535.
@article{18892b45c7334a8dbd615131b72fa9ab,
title = "Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review",
abstract = "Objective: Large muscular or musculotendinous defects present a dilemma because of the inadequacies of current treatment strategies. Extracellular matrices (ECM) are potential clinically applicable regenerative biomaterials. This review summarizes information from the preclinical literature evaluating the use of ECM for muscle regeneration in animal models of volumetric muscle loss (VML). Study Design: Literature review. Sample population: Animal models of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Methods: PubMed, Google Scholar, CAB abstracts, and Scopus were searched for preclinical studies using ECM in animal models of VML. The search terms “extracellular matrix,” “VML,” “muscle regeneration,” “cell seeded,” and “scaffold” identified 40 articles that met inclusion criteria of an animal model of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Key skeletal muscle repair mechanisms and experimental findings on scaffold type, VML location, and experimental animal species were summarized. Conclusions: Satellite cells and basal lamina are key endogenous contributors to skeletal muscle regeneration. ECM as a dynamic tissue component may provide structural integrity, signaling molecules, and a 3-dimensional topography conducive to muscle regeneration. Preclinical models of muscle repair most commonly used mice and rats (88{\%}). Most experimental lesions were created in abdominal wall (33{\%}), anterior tibialis (33{\%}), latissimus dorsi (10{\%}), or quadriceps (10{\%}) muscles. Matrices varied markedly in source and preparation. Experimental outcomes of ECM and cell-seeded ECM implantation for muscle regeneration in VML were highly variable and dependent on matrix tissue source, preparation method, and anatomic site of injury. Scar tissue formation likely contributes to load transfer. Nonappendicular lesions had better regenerative results compared with appendicular VML. Clinical significance: The preponderance of current evidence supports the use of ECM for muscle defect repair only in specific instances, such as nonappendicular and/or partial-thickness defects. Consequently, clinical use of ECM in veterinary patients requires careful consideration of the specific ECM product, lesion size and location, and loading circumstances.",
author = "Sarrafian, {Tiffany L.} and Bodine, {Sue C.} and Murphy, {Brian G} and Grayson, {J. Kevin} and Stover, {Susan M}",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/vsu.12787",
language = "English (US)",
volume = "47",
pages = "524--535",
journal = "Veterinary Surgery",
issn = "0161-3499",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Extracellular matrix scaffolds for treatment of large volume muscle injuries

T2 - A review

AU - Sarrafian, Tiffany L.

AU - Bodine, Sue C.

AU - Murphy, Brian G

AU - Grayson, J. Kevin

AU - Stover, Susan M

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Objective: Large muscular or musculotendinous defects present a dilemma because of the inadequacies of current treatment strategies. Extracellular matrices (ECM) are potential clinically applicable regenerative biomaterials. This review summarizes information from the preclinical literature evaluating the use of ECM for muscle regeneration in animal models of volumetric muscle loss (VML). Study Design: Literature review. Sample population: Animal models of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Methods: PubMed, Google Scholar, CAB abstracts, and Scopus were searched for preclinical studies using ECM in animal models of VML. The search terms “extracellular matrix,” “VML,” “muscle regeneration,” “cell seeded,” and “scaffold” identified 40 articles that met inclusion criteria of an animal model of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Key skeletal muscle repair mechanisms and experimental findings on scaffold type, VML location, and experimental animal species were summarized. Conclusions: Satellite cells and basal lamina are key endogenous contributors to skeletal muscle regeneration. ECM as a dynamic tissue component may provide structural integrity, signaling molecules, and a 3-dimensional topography conducive to muscle regeneration. Preclinical models of muscle repair most commonly used mice and rats (88%). Most experimental lesions were created in abdominal wall (33%), anterior tibialis (33%), latissimus dorsi (10%), or quadriceps (10%) muscles. Matrices varied markedly in source and preparation. Experimental outcomes of ECM and cell-seeded ECM implantation for muscle regeneration in VML were highly variable and dependent on matrix tissue source, preparation method, and anatomic site of injury. Scar tissue formation likely contributes to load transfer. Nonappendicular lesions had better regenerative results compared with appendicular VML. Clinical significance: The preponderance of current evidence supports the use of ECM for muscle defect repair only in specific instances, such as nonappendicular and/or partial-thickness defects. Consequently, clinical use of ECM in veterinary patients requires careful consideration of the specific ECM product, lesion size and location, and loading circumstances.

AB - Objective: Large muscular or musculotendinous defects present a dilemma because of the inadequacies of current treatment strategies. Extracellular matrices (ECM) are potential clinically applicable regenerative biomaterials. This review summarizes information from the preclinical literature evaluating the use of ECM for muscle regeneration in animal models of volumetric muscle loss (VML). Study Design: Literature review. Sample population: Animal models of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Methods: PubMed, Google Scholar, CAB abstracts, and Scopus were searched for preclinical studies using ECM in animal models of VML. The search terms “extracellular matrix,” “VML,” “muscle regeneration,” “cell seeded,” and “scaffold” identified 40 articles that met inclusion criteria of an animal model of VML in which surgical repair was performed with an ECM product, with or without added cell populations. Key skeletal muscle repair mechanisms and experimental findings on scaffold type, VML location, and experimental animal species were summarized. Conclusions: Satellite cells and basal lamina are key endogenous contributors to skeletal muscle regeneration. ECM as a dynamic tissue component may provide structural integrity, signaling molecules, and a 3-dimensional topography conducive to muscle regeneration. Preclinical models of muscle repair most commonly used mice and rats (88%). Most experimental lesions were created in abdominal wall (33%), anterior tibialis (33%), latissimus dorsi (10%), or quadriceps (10%) muscles. Matrices varied markedly in source and preparation. Experimental outcomes of ECM and cell-seeded ECM implantation for muscle regeneration in VML were highly variable and dependent on matrix tissue source, preparation method, and anatomic site of injury. Scar tissue formation likely contributes to load transfer. Nonappendicular lesions had better regenerative results compared with appendicular VML. Clinical significance: The preponderance of current evidence supports the use of ECM for muscle defect repair only in specific instances, such as nonappendicular and/or partial-thickness defects. Consequently, clinical use of ECM in veterinary patients requires careful consideration of the specific ECM product, lesion size and location, and loading circumstances.

UR - http://www.scopus.com/inward/record.url?scp=85048039049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048039049&partnerID=8YFLogxK

U2 - 10.1111/vsu.12787

DO - 10.1111/vsu.12787

M3 - Review article

C2 - 29603757

AN - SCOPUS:85048039049

VL - 47

SP - 524

EP - 535

JO - Veterinary Surgery

JF - Veterinary Surgery

SN - 0161-3499

IS - 4

ER -